Can a wealthy family change the course of a deadly brain disease?
Summary
The article examines how a wealthy family's philanthropy can influence the direction of research into a deadly brain disease, highlighting potential benefits such as accelerating discovery and potential drawbacks like agenda bias and lack of transparency. It discusses governance, transparency, and safeguards to ensure research remains open and patient-centered, offering insights for researchers and funders on balancing speed with rigorous, unbiased inquiry.